BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2019
View Archived Issues
Repair enables regeneration for blood vessels
Read More
Prelude Therapeutics initiates phase I study of PRT-543 in advanced malignancies
Read More
Phase I results of pegargiminase, cisplatin and pemetrexed in ASS1-deficient high-grade glioma
Read More
Discovery and characterization of a novel selective LMP7 inhibitor for multiple myeloma
Read More
Novel bispecific T-cell engager CAR therapy overcomes glioblastoma heterogeneity
Read More
GlaxoSmithKline presents preclinical data for GSK-102
Read More
Development of new long-term animal model of Graves' disease verified
Read More
Enrollment open in phase IIb study of dalcinonacog alfa for hemophilia B
Read More
Theralase's phase Ib study of TLD-1433 shows 66% CR at therapeutic dose 360 days post treatment
Read More
ViGenCell opens enrollment in phase II trial of VT-EBV-N for EBV-positive patients with ENKL
Read More
BioArctic receives grant for collaborative research to improve immunotherapy for CNS disorders
Read More
Pfizer begins phase I study of PF-06939999 in advanced or metastatic solid tumors
Read More
European Commission approves Vizimpro for first-line treatment of EGFR-mutated NSCLC
Read More
Daiichi Sankyo presents oral TIP48/TIP49 inhibitors for the treatment of hematological cancer
Read More
TUL-001 potently inhibits tumor growth in NSCLC brain metastasis model
Read More
Sangamo provides clinical development update
Read More
Stem cell-derived human 'hearts' identify new cardiac drugs
Read More
Shenzhen Biocan Technologies patents APP-targeting shRNAs
Read More
Shenzhen Biocan Technologies identifies new IDO-targeting shRNAs
Read More
TNFRSF18-targeting shRNAs described in Shenzhen Biocan Technologies patent
Read More
U.S. researchers synthesize antisense oligonucleotides targeting MYC
Read More
Bluevalley Pharmaceutical discloses ATR inhibitors
Read More
Preclinical results of EI-1071, a selective CSF1R inhibitor regulating tumor-associated macrophages
Read More
Comparison of the novel biguanide NT-1195 with metformin/phenformin in endometrial cancer models
Read More
Phase I results of highly selective dual IDO1/TDO2 inhibitor M-4112 in advanced solid malignancies
Read More